TM BIOSCIENCE
Tm Bioscience Corporation, a DNA-based diagnostics company, engages in developing a suite of genetic tests principally in Canada and the United States. Its product pipeline includes tests for genetic mutations related to human disease, pharmacogenetics, and infectious disease. The company's primary product includes Tag-It Mutation Detection Kit for the P450-2D6 drug metabolism gene; Tag-It CFTR 40+4 mutation detection kit detecting 40 mutations and 4 variants in the Cystic Fibrosis gene; and a custom developed Cystic Fibrosis CFTR 70 test for specialty laboratories.
TM BIOSCIENCE
Industry:
Biotechnology Genetics Health Care Health Diagnostics
Founded:
1980-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Status:
Active
Total Funding:
13 M USD
Similar Organizations
Compendia Bioscience
Compendia Bioscience is dedicated to applying the global collection of cancer genomic data to impact patient treatment by enabling the
Parabase Genomics
Parabase Genomics is a molecular diagnostics company that focuses on the development of treatments for genetic disorders.
Investors List
Laurus Funds
Laurus Funds investment in Venture Round - TM Bioscience
Laurus Funds
Laurus Funds investment in Venture Round - TM Bioscience